ctrl K

Mineralys Therapeutics In... (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

14.95

0.74 (5.21%)

At close: May 01, 2025, 3:59 PM

Mineralys Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
PE Ratio	-3.36	-4.33	-25.28	-37.11	-210.22
PEG Ratio	-0.04	-0.03	-0.55	-0.08	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a
PB Ratio	3.12	1.29	-14.41	-31.42	-200.22
P/FCF Ratio	-3.59	-3.83	-25.78	-49.47	-292.41
P/OCF Ratio	-3.59	-3.83	-25.78	-49.47	-292.41
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	n/a	n/a	n/a	n/a	-1.25
Quick Ratio	14.02	23.76	13.65	2.20	0.29
Current Ratio	14.02	23.76	13.65	2.20	0.29
Asset Turnover	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	-18.78	-693.52	-25.59
Return on Equity	-0.93	-0.3	0.57	0.85	0.95
Return on Assets	-0.86	-0.29	-0.26	-1.74	-2.31
Return on Invested Capital	-1.01	-0.35	-0.28	-3.09	-3.37
Dividend Yield	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a